Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 1, 2002, Pages 39-47

  Farrell, D J ^a   Morrissey, I ^a   Bakker, S ^a   Felmingham, D ^a  

^a GR Micro Ltd   (United Kingdom)

Author keywords

Macrolide resistance; Molecular characterization; Streptococcus pneumoniae; Streptococcus pyogenes

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; TELITHROMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG POTENCY; EUROPE; GENETIC MARKER; GENOTYPE; GEOGRAPHY; HUMAN; LONGITUDINAL STUDY; LOWER RESPIRATORY TRACT INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; NORTH AMERICA; PATHOGENESIS; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0036732832     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf806     Document Type: Article

References (38)

1. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander Project 1992-1996
2. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998
3. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella calarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999
4. Community-acquired pneumonia in adults: Guidelines for management. The Infectious Diseases Society of America
5. Diagnosis and management of group A streptococcal pharyngitis: A practice guideline. Infectious Diseases Society of America
6. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus
7. Erythromycin resistance by ribosome modification
8. Substrate- and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites
9. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants
10. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece
11. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
12. Macrolide resistance conferred by base substitutions in 23S rRNA
13. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae
14. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
15. Incidence of mefA and ermB among macrolide resistant Streptococcus pneumoniae (SPN) isolated in Canada during 1998 and 1999
16. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients
17. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States
18. The need for antimicrobial resistance surveillance
19. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization
20. Distribution of macrolide resistance genes erm(B) and meAA) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France
21. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
22. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: Results of a national surveillance study
23. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Observatoire de Normandie du Pneumocoque
24. Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
25. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
26. Macrolide resistance determinants distribution in Streptococcus pneumoniae isolates from Italy, Spain and U.K. and their susceptibility to HMR 3647 after induction with erythromycin
27. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France
28. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics
29. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: Characterization of South African isolates
30. New mechanisms of macrolide resistance detected in clinical isolates of Streptococcus pneumoniae
31. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany
32. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada
33. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain
34. Erythromycin resistance genes in group A streptococci in Finland
35. In vitro activity of midecamycin diacetate, a 16-membered macrolidle, against Streptococcus pyogenes isolated in France, 1995-1999
36. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan
37. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
38. Evolving resistance patterns of Streptococcus pneumoniae: A link with long-acting macrolide consumption?